Phosphatidylinositol-4-phosphate 5-kinase type II beta (PIP4K2B)

Phosphatidylinositol-4-phosphate 5-kinase type II beta (PIP4K2B) is a lipid kinase that predominantly localizes to nuclear and autophagosomal membranes, catalyzing the phosphorylation of phosphatidylinositol 5-phosphate (PI(5)P) to generate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂). This reaction is crucial for cell signaling, cytoskeletal organization, and subcellular compartment function. The enzyme interacts with other PIP kinases, regulates insulin signaling independently of its catalytic activity, and is implicated in cancer and metabolic disease. No approved drugs currently target PIP4K2B directly, but related kinase inhibitors are under investigation. The molecule is properly named, functionally classified, and relevant as a therapeutic target in molecular pharmacology.

Other names

PI5P4KβPIP4K2B1-phosphatidylinositol-5-phosphate 4-kinase beta

Small molecule inhibition of kinase activity. Modulation of PI(4,5)P₂ levels to affect downstream signaling (e.g., PLC or PI3K pathways). Catalytic-independent regulation of insulin signaling by interaction with PIP5Ks.